New hope for breast cancer patients: drug cuts hot flashes without hormones
NCT ID NCT06440967
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 18 times
Summary
This study tests fezolinetant, a non-hormonal drug, for treating hot flashes in women with hormone-positive breast cancer who are on hormone therapy. About 984 women will take either fezolinetant or a placebo daily for a year. The goal is to see if the drug reduces how often and how severe hot flashes are, improving quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOT FLASHES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site CA15001
Québec, Quebec, Canada
-
Site CA15002
Montreal, Quebec, Canada
-
Site CA15003
Sherbrooke, Quebec, Canada
-
Site CA15004
Québec, Quebec, Canada
-
Site CA15007
Trois-Rivières, Canada
-
Site CA15016
Sault Ste. Marie, Ontario, Canada
-
Site CA15019
Sarnia, Ontario, Canada
-
Site CA15020
Victoriaville, Quebec, Canada
-
Site CZ42001
Olomouc, Czechia
-
Site CZ42002
Hradec Králové, Czechia
-
Site CZ42003
Hořovice, Czechia
-
Site CZ42004
Tábor, Czechia
-
Site CZ42005
Prague, Czechia
-
Site CZ42006
České Budějovice, Czechia
-
Site CZ42007
Vodňany, Czechia
-
Site CZ42008
Prague, Czechia
-
Site CZ42009
Vsetín, Czechia
-
Site CZ42011
Nový Jičín, Czechia
-
Site CZ42013
Prague, Czechia
-
Site DE45003
Esbjerg, Denmark
-
Site DE45008
Sønderborg, Denmark
-
Site DE49001
Bottrop, Germany
-
Site DE49007
Mönchengladbach, Germany
-
Site DE49009
Leipzig, Germany
-
Site DE49010
München, Germany
-
Site DK45002
Næstved, Denmark
-
Site DK45007
Aalborg, Denmark
-
Site DK45009
Hillerød, Denmark
-
Site ES34002
Murcia, Spain
-
Site ES34003
Girona, Spain
-
Site ES34005
Granada, Spain
-
Site ES34006
Jaén, Spain
-
Site ES34007
Madrid, Spain
-
Site ES34008
Palma, Spain
-
Site ES34009
Seville, Spain
-
Site ES34010
Elche, Spain
-
Site ES34011
Barcelona, Spain
-
Site ES34013
Valencia, Spain
-
Site ES34014
Murcia, Spain
-
Site ES34015
Majadahonda, Spain
-
Site ES34017
León, Spain
-
Site ES34019
Madrid, Spain
-
Site ES34020
Barcelona, Spain
-
Site ES34022
Madrid, Spain
-
Site ES34023
Madrid, Spain
-
Site ES34024
Seville, Spain
-
Site ES34025
Rivas-Vaciamadrid, Spain
-
Site FR33001
Bayonne, France
-
Site FR33002
Saint-Herblain, France
-
Site FR33003
Angers, France
-
Site FR33005
Bordeaux, France
-
Site FR33007
Lille, France
-
Site FR33008
Montpellier, France
-
Site FR33012
Lyon, France
-
Site FR33013
Le Mans, France
-
Site FR33016
Dijon, France
-
Site FR33017
Caen, France
-
Site FR33018
Bordeaux, France
-
Site GB44001
Preston Lancashire, United Kingdom
-
Site GB44002
Liverpool, United Kingdom
-
Site GB44003
Bristol, United Kingdom
-
Site GB44005
London, United Kingdom
-
Site GB44006
Glasgow, United Kingdom
-
Site GB44008
Bebington, Birkenhead, United Kingdom
-
Site GB44009
Guildford, Surrey, United Kingdom
-
Site GB44010
Stroke on Trent, United Kingdom
-
Site GB44012
Redhill, United Kingdom
-
Site GB44016
Cambridge, United Kingdom
-
Site GB44017
Oxford, United Kingdom
-
Site GB44018
Aberdeen, United Kingdom
-
Site GB44019
Birmingham, United Kingdom
-
Site GB44020
Liverpool, United Kingdom
-
Site GR49003
Münster, Germany
-
Site GR49005
Essen, North Rhine-Westphalia, Germany
-
Site GR49013
Dresden, Germany
-
Site GR49014
Wolfsburg, Germany
-
Site HU36001
Eger, Hungary
-
Site HU36002
Kecskemét, Hungary
-
Site HU36003
Székesfehérvár, Hungary
-
Site HU36006
Debrecen, Hungary
-
Site HU36008
Budapest, Hungary
-
Site HU36010
Salgótarján, Hungary
-
Site IT39003
Milan, Italy
-
Site IT39011
Bologna, Italy
-
Site IT39012
Terni, Italy
-
Site IT39013
Mirano, Italy
-
Site IT39015
Genova, Italy
-
Site IT39017
Pavia, Italy
-
Site IT39018
Reggio Emilia, Italy
-
Site NL31001
Haarlem, Netherlands
-
Site NL31002
Rotterdam, Netherlands
-
Site NL31004
Rotterdam, Netherlands
-
Site NL31006
Dirksland, Netherlands
-
Site NL31009
Terneuzen, Netherlands
-
Site NL31010
Breda, Netherlands
-
Site NL31012
Rotterdam, Netherlands
-
Site PO48001
Warsaw, Poland
-
Site PO48002
Poznan, Poland
-
Site PO48003
Świdnik, Poland
-
Site PO48004
Katowice, Poland
-
Site PO48005
Bialystok, Poland
-
Site PO48006
Bydgoszcz, Poland
-
Site PO48007
Lodz, Poland
-
Site PO48010
Szczecin, Poland
-
Site PO48012
Lodz, Poland
-
Site PO48015
Krakow, Poland
-
Site PO48017
Katowice, Poland
-
Site PO48018
Poznan, Poland
-
Site PO48019
Poznan, Skorzewo, Poland
-
Site PO48021
Krakow, Poland
Conditions
Explore the condition pages connected to this study.